CD4 and hepatotoxicity: The rates of NVP- and ZDV-related SAEs were generally consistentwith those reported in the prescribing information from the drug manufacturers[17],[18], although we didnot find a significant increase in NVP-related hepatotoxicity and rash amongmothers with CD4 counts above 250 cells/mm3 as had been reported innonpregnant women in other trials.